For the 300,000 Americans living with the immune disease scleroderma, better treatments can't come soon enough. The rare and ...

For the 300,000 Americans living with the immune disease scleroderma, better treatments can't come soon enough. The rare and ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

A study by investigators at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues from Rabin Medical ...

The operational cleavage between the US public health and medical care systems contributed to the country’s difficulty in containing community spread of COVID-19 in the pandemic’s first months ...

An international team led by Einstein Professor Cecilia Clementi in the Department of Physics at Freie Universität Berlin ...

3D bioprinting is offering a new direction to repair damaged tissues while minimising the requirement of organ transplants, but – despite this immense progress – there are several challenges: 1.